These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23103199)

  • 1. Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization.
    Stano A; Nembrini C; Swartz MA; Hubbell JA; Simeoni E
    Vaccine; 2012 Dec; 30(52):7541-6. PubMed ID: 23103199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration.
    Stano A; van der Vlies AJ; Martino MM; Swartz MA; Hubbell JA; Simeoni E
    Vaccine; 2011 Jan; 29(4):804-12. PubMed ID: 21094269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization.
    Fromen CA; Robbins GR; Shen TW; Kai MP; Ting JP; DeSimone JM
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):488-93. PubMed ID: 25548169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
    Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N
    J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity.
    Noh YW; Hong JH; Shim SM; Park HS; Bae HH; Ryu EK; Hwang JH; Lee CH; Cho SH; Sung MH; Poo H; Lim YT
    Angew Chem Int Ed Engl; 2013 Jul; 52(30):7684-9. PubMed ID: 23765547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles.
    Stano A; Scott EA; Dane KY; Swartz MA; Hubbell JA
    Biomaterials; 2013 Jun; 34(17):4339-46. PubMed ID: 23478034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with liposomes induces strong mucosal immune responses in mice.
    Vadolas J; Davies JK; Wright PJ; Strugnell RA
    Eur J Immunol; 1995 Apr; 25(4):969-75. PubMed ID: 7737300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
    Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
    Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles.
    Uto T; Wang X; Akagi T; Zenkyu R; Akashi M; Baba M
    Biochem Biophys Res Commun; 2009 Feb; 379(2):600-4. PubMed ID: 19121627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
    Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
    J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.
    Howe SE; Konjufca VH
    PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early immune responses in Atlantic salmon (Salmo salar L.) after immunization with PLGA nanoparticles loaded with a model antigen and β-glucan.
    Fredriksen BN; Sævareid K; McAuley L; Lane ME; Bøgwald J; Dalmo RA
    Vaccine; 2011 Oct; 29(46):8338-49. PubMed ID: 21888940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo.
    Powell TJ; Palath N; DeRome ME; Tang J; Jacobs A; Boyd JG
    Vaccine; 2011 Jan; 29(3):558-69. PubMed ID: 20951665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization promotes th17 immune responses.
    Zygmunt BM; Rharbaoui F; Groebe L; Guzman CA
    J Immunol; 2009 Dec; 183(11):6933-8. PubMed ID: 19890060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses.
    Cui Z; Mumper RJ
    J Pharm Pharmacol; 2002 Sep; 54(9):1195-203. PubMed ID: 12356273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antigen-specific CD4
    Weilhammer D; Dunkle AD; Blanchette CD; Fischer NO; Corzett M; Lehmann D; Boone T; Hoeprich P; Driks A; Rasley A
    Vaccine; 2017 Mar; 35(11):1475-1481. PubMed ID: 28214044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.